Form 4 for BC BRUNSWICK CORP
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0000014930-23-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-21 | 2023-02-16 | BC | Dekker Christopher F | EVP. GEN COUNSEL, Sec | S - Sale | $88.29 | -7,353 | 41.5K | -15% | -$649.2K | |
| 2023-02-21 | 2023-02-16 | BC | Dekker Christopher F | EVP. GEN COUNSEL, Sec | F - Tax | $88.45 | -4,257 | 48.8K | -8% | -$376.5K | |
| M | 2023-02-21 | 2023-02-16 | BC | Dekker Christopher F | EVP. GEN COUNSEL, Sec | A - Grant | $88.45 | +14.1K | 53.1K | +36% | +$1.25M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | S | D | 7,353 | $88.29 | 41,455 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.79 to $88.78. |
| 2 | Common | Common Stock | 2023-02-16 | F | D | 4,257 | $88.45 | 48,808 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-16 | A | A | 9,610 | $88.45 | 48,545 | D | — | — | (F1) Shares were acquired pursuant to the officer's 2020 performance share grant that was released on February16,2023. |
| 4 | Common | Common Stock | 2023-02-16 | A | A | 4,520 | $88.45 | 53,065 | D | — | — | (F2) Restricted stock granted under the 2014 Stock Incentive Plan with right to have shares withheld to pay income taxes on lapse of restrictions. |